Campbell & Co Investment Adviser’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-74,717
Closed -$1.7M – 1056
2025
Q2
$1.7M Buy
74,717
+40,592
+119% +$962K 0.11% 298
2025
Q1
$1.03M Buy
+34,125
New +$1.3M 0.08% 416
2024
Q2
– Sell
-6,338
Closed -$502K – 1011
2024
Q1
$502K Buy
6,338
+3,760
+146% +$307K 0.04% 693
2023
Q4
$200K Sell
2,578
-4,779
-65% -$354K 0.02% 1035
2023
Q3
$517K Buy
7,357
+4,705
+177% +$352K 0.06% 501
2023
Q2
$211K Sell
2,652
-494
-16% -$35.7K 0.04% 793
2023
Q1
$227K Sell
3,146
-1,845
-37% -$144K 0.04% 701
2022
Q4
$411K Buy
+4,991
New +$411K 0.1% 404
2022
Q2
– Sell
-14,274
Closed -$935K – 659
2022
Q1
$935K Buy
14,274
+9,882
+225% +$574K 0.25% 83
2021
Q4
$267K Buy
+4,392
New +$262K 0.09% 407
2020
Q1
– Sell
-12,610
Closed -$419K – 23
2019
Q4
$419K Buy
+12,610
New +$395K 0.13% 292

Other funds holding ACHC

Campbell & Co Investment Adviser's ACHC Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 74,717 shares — an estimated $1.7M sold.

Campbell & Co Investment Adviser first reported a position in ACHC in Q4 2019 and held it in 11 quarters. The position peaked at $1.7M in Q2 2025. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 74,717 Acadia Healthcare shares in Q3 2025, an estimated $1.7M.
  • Campbell & Co Investment Adviser first reported a position in Acadia Healthcare in Q4 2019 and held it in 11 quarters.
  • Campbell & Co Investment Adviser's Acadia Healthcare position peaked at $1.7M in Q2 2025.
  • 270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.